H.R. 863 · 116th Congress

DXM Abuse Prevention Act of 2019

Stage
In committee
Introduced
2019-01-30
Latest action
2019-01-30 · Introduced in House

Summary

DXM Abuse Prevention Act of 2019

This bill addresses the sale and distribution of dextromethorphan (DXM).

Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.

The bill also establishes restrictions on (1)the sale of over-the-counter drugs containing DXM, and (2)the distribution of bulk DXM.